a b s t r a c t Double strand DNA breaks (DSBs) are one of the most challenging forms of DNA damage which, if left unrepaired, can trigger cellular death and can contribute to cancer. A number of studies have been focused on DNA-damage response (DDR) mechanisms, and most of them rely on the induction of DSBs triggered by chemical compounds or radiations. However, genotoxic drugs and radiation treatments of cultured cell lines induce random DSBs throughout the genome, thus heterogeneously across the cell population, leading to variability of the cellular response. To overcome this aspect, we used here a recently described cell-based DSBs system whereby, upon induction of an inducible restriction enzyme, hundreds of sitespecific DSBs are generated across the genome. We show here that sequence-specific DSBs are sufficient to activate the positive transcription elongation factor b (P-TEFb), to trigger hyperphosphorylation of the largest RNA polymerase II carboxyl-terminal-domain (Rpb1-CTD) and to induce activation of p53-transcriptional axis resulting in cell cycle arrest.
Introduction
DNA damage represents an impressive challenge to the integrity of genetic material and cells have evolved multifaceted mechanisms collectively termed the DNA damage response (DDR) to detect, sign and properly respond to various DNA injuries. DDR induces a global transcription reprogramming called transcriptional stress response (TSR) with the majority of genes being repressed. A subset of genes are activated in TSR, among them those whose activity is required to halt the cell cycle and repair the damage or eventually carry the cells toward apoptosis [1] [2] [3] [4] [5] .
A common feature of cellular response to DNA damage induced by UV light, X-ray irradiation or different genotoxic drugs is hyperphosphorylation of CTD of the largest Rpb1 subunit of RNA polymerase II (Rpb1-CTD) [6, 7] . Rpb1-CTD represents the docking site for a number of factors that, by interacting with and inducing its phosphorylation/dephosphorylation at Ser/Thr residues, regulate its activity as well as transcription progression along the gene unit and associated co-transcriptional events [8, 9] . P-TEFb is one of the kinases that are involved in the regulation of RNA poly-merase II (RNAPII) activity by phosphorylating the Rpb1-CTD tail during the transcriptional cycle. P-TEFb activity is regulated by a dynamic equilibrium between the small active complex (SC), made of CDK9/CyclinT1, and the large inactive complex (LC) where CDK9/CycT1 are associated to a snRNP complex made of 7SK snRNA, Hexim1, MeCPE and Larp7 [10] [11] [12] [13] [14] . The dynamic equilibrium between SC and LC P-TEFb complexes can be perturbed by transcriptional arrest, hypertrophic signals and by a variety of DNA-damaging agents that induce a rapid release of the P-TEFb LC complex with a concomitant accumulation of the active P-TEFb complex [15] [16] [17] [18] [19] [20] [21] .
A number of studies have been focused on RNAPII transcription stalling in the presence of UV induced lesions, while the behavior of RNAPII when encounters a DSB lesion is a relative recent argument whose findings are still controversial, as recently discussed by Pankotai and Soutoglou [22 and references therein] . It has been suggested that the number and topology of the breaks may affect the molecular mechanisms mediating arrest of RNAPII [22] [23] [24] . Because the induction of DSBs triggered by chemical compounds or radiations of cultured cell lines causes random DSBs throughout the genome, several systems have been developed that rely on the use of restriction enzymes capable to generate unambiguously positioned sequence-specific DSBs, thus inducing a homogeneous, sequence specific, reproducible DNA damage [25] [26] [27] [28] . Here we addressed whether sequence specific DSBs affect the [28] . We found that sitespecific DSBs trigger disruption of the P-TEFb LC complex leading to accumulation of active SC P-TEFb. Moreover, as consequence, we found hyperphosphorylation of Rpb1-CTD. In the same experimental conditions we also observed activation of the p53-dependent transcriptional pathway and cell cycle arrest.
Materials and methods

Cell culture and drug treatments
HA-AsiSI-ER-U2OS (AsiSI) and U2OS cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum and 1 mg/ml puromycin at 37
• C in humidified atmosphere with 5% CO2. Induction of HA-AsiSI-ER chimera was carried out as described in Iacovoni et al. [28] using 4-OHT (300 nM, from Sigma Aldrich). Doxorubicin (1 M), camptothecin (12 M) and nutlin-3 (10 M) are from Sigma Aldrich. Flavopiridol (50 nM) was obtained from NIH AIDS research and Reference Reagent Program (Cat. #9925).
RNA interference
The following small interference RNA reagents (siRNAs) were purchased from Dharmacon: On Target Plus SMART pool targeting CDK9 (L-003243), On Target Plus non-target pool (D-001830-20).
AsiSI cells transfected with 100 nM siRNA targeting CDK9 or with scramble, non-targeting siRNA pool using MicroPorator Digital Bio Technology, a pipette-type electroporation system (Seoul, Korea). siRNAs were introduced into each 3 × 10 6 dissociated cells in 100 l volume according to manufacturer's instructions (1230 V, 10 width, 4 pulses) and seeded in 100 mm culture dishes as previously reported [29] . After 48 h, cells were treated for 8 h with 4-OHT or vehicle (NT). After the treatments, cells were collected and extracts prepared as described in next paragraph.
Glycerol gradient, co-immunoprecipitation and immunoblotting
Whole-cell extracts were obtained using buffer A [11] . For glycerol gradient, protein extracts were ultracentrifuged at 40,000 rpm for 16 h at 4
• C in SW40.1 rotor on a pre-formed 5-45% discontinuous glycerol gradient containing buffer A. Samples were collected in 10 fractions (1 ml each starting from the top), and 20 l of each fraction were separated by SDS-PAGE and analyzed by western blotting using appropriate antibodies.
Co-immunoprecipitation analyses were performed using whole-cell extracts (1 mg) incubated with the anti-Cyclin T1 (sc-10750) antibody. After extensive washes the recovered beads were resuspended in Laemmli buffer, resolved on SDS-PAGE and analyzed by western blotting.
The following antibodies were used: mouse monoclonal anti-8WG16 (MMS 126R) and mouse monoclonal anti-H5 (MMS 129R) from Covance, Inc.; rabbit polyclonal anti-Cdk9 (sc 8338), goat polyclonal anti-Cyclin T1 (sc-8127), mouse monoclonal anti-p53 (sc-126), rabbit polyclonal anti-p21 (sc-397), mouse monoclonal anti-actinin (sc-17829), mouse monoclonal anti-Cyclin B1 (sc-215) and rabbit polyclonal anti-Cyclin T1 (sc-10750) from Santa Cruz Biotechnology, Inc., Santa Cruz, CA; mouse monoclonal anti-P-p53 Ser15 (9286) from Cell Signaling Technology, Inc.; the rabbit polyclonal anti-Hexim1 (C4) was already described [30] . Binding was visualized by enhanced chemiluminescence (ECL-plus Kit, Amersham Biosciences).
Immunofluorescence and co-localization assays
Cells at the density of 5 × 10 4 were grown on coverslips in 2.5 cm dishes. Immunofluorescence was carried out as previously described [31] . Briefly, for immunofluorescence, U2OS cells were fixed and stained with rabbit anti-␥H2AX (Cell Signaling Technology Inc.) for 30 at 37
• C after brief permeabilization (0,1% Triton X-100/PBS) and pre-blocking (2% BSA-3% NRS) steps. After extensive washes, anti-rabbit-Cy3 secondary antibody has been used at the dilution of 1:400 for 30 at room temperature. For co-localization analyses, after fixation and pre-blocking (2%BSA-3%NS), AsiSI cells were stained with both rabbit anti-␥H2AX and mouse anti-HA (Invitrogen Corporation) for 30 min at 37
• C. Anti-mouse-Cy3 and antirabbit-FITC (Jackson Immunotech, West Grove, PA) secondary antibodies have been used after washes to detect mouse anti-HA and rabbit anti-␥H2AX respectively. Nuclei were stained with DAPI (Invitrogen Corporation). Images were acquired using a Nikon Eclipse TE 2000-U microscope and digitally processed using Adobe Photoshop CS4 software.
qRT-PCR
cDNA was prepared from total RNA (1 mg) with Quantitec Reverse Transcription Kit (Qiagen) according to manufacturer's protocol. cDNA of each sample was prepared in triplicate and normalized to the expression of the housekeeping betaglucoronidase (GUS) as previously described [18, 19] . Quantitative analyses were performed using SYBR GREEN 2X PCR Master Mix (Applied Biosystems). Reactions were run in the AbiPrism 7900 HT sequence detector system (Perkin-Elmer Applied Biosystems). All values represent the average of at least three independent experiments. DNA sequences of the oligos used in this work are available upon request.
FACS analyses
For monoparametric DNA profile cells were treated as indicated in the text, collected by centrifugation and washed in phosphate-buffered saline (PBS). Cells were resuspended in hypotonic solution 0.1%Na-Citrate, 50 g/ml propidium iodide, 50 g/ml RNAse, and 0.00125% Nonidet P40, incubated in absence of light for 30 at room temperature and diluted at the final concentration of 1 × 10 5 cells/ml. Biparametric BrdU/DNA analysis: cells were treated as already described [32] . Briefly, after a 20 min pulse with 10 M 5-bromo-2-deoxyuridine (BrdU, from Sigma Aldrich), culture medium was changed and cells were treated as indicated in the text. After treatments, cells were fixed with ice-cold ethanol, washed with PBS/1% BSA and subjected to a denaturation step with 2 N HCl for 25 min at room temperature. Denaturation was stopped with 0.1 M Na2B4O7. After washes with PBS/1% BSA, cells were incubated with anti-BrdU (cat. No. 347580, Becton Dickinson) in PBS/1% BSA. After incubation with the secondary anti-mouse FITC (F2883, Sigma Aldrich) cells were washed and incubated in absence of light overnight with PI (2.5 g/ml) and RNAse (50 g/ml). Cytofluorimetric acquisitions and analyses were performed on a Becton Dickinson FACScalibur flow cytometer using FACSDiva, CellQuest Pro and ModFit LT 3.0 softwares.
Results and discussion
AsiSI induced DSBs trigger P-TEFb-dependent Rpb1-CTD hyperphosphorylation
A common feature of the cellular response to UV radiations and drug-induced DNA damage is the induction of a high phosphorylation degree of the Rpb1-CTD [6, 7, 33] . The CTD tail of Rpb1 serves as a scaffold for the interaction of a wide range of factors that orchestrate transcription and co-transcriptional processes, and it has been suggested that the hyper-phosphorylated status of the CTD represents a signal for rapid Rpb1 proteasomal degradation [34] [35] [36] .
However, in-depth understanding of the functional consequences of hyper-phosphorylation triggered by diverse DNA damaging agents has been hampered because most DNA damaging agents act non-selectively throughout the genome, generating a heterogeneous genotoxic response. Here we used an inducible restriction enzyme cellular system whereby hundreds of DSBs are generated across the genome. AsiSI cells express the 8 bp restriction enzyme AsiSI fused to HA epitope and to a modified estrogen receptor ligand binding domain that induces nuclear localization of the enzyme only after 4-OHT administration to cells [28] .
As shown in Fig. 1A , we observed nuclear accumulation of HAAsiSI-ER chimera by immunofluorescence analysis of AsiSI cells treated with 4-OHT for increasing time, and we detected appearance of ␥-H2AX foci after 0.5 h following drug administration.
Then we tested CTD-Rpb1 phosphorylation status following DSBs generation. Western blots analyses showed that CTD hyperphosphorylation takes place after 2 h of 4-OHT treatments (Fig. 1B) . Using 8WG16 antibody that recognizes the unphosphorylated heptapeptides of the CTD thus detecting total Rpb1 (that is, all isoforms), we observed accumulation of the slower II o band (mostly hyper-phosphorylated) and a concomitant decrease of the faster hypo-phosphorylated II a form of Rpb1. The hyper-phosphorylation of Rpb1-CTD increased during time of treatment as documented by the ratio between the hyper-phosphorylated II o and hypophosphorylated II a forms of CTD. We included in our experiments treatment with Camptothecin (CPT) that is known to induce DSBs [37] . CTD hyper-phosphorylation was also assayed using the anti-H5 antibody that mainly recognizes the phospho-Ser2-CTD. To exclude that 4-OHT treatment could directly affect Rpb1-CTD phosphorylation, we treated the parental U2OS cell line with 4-OHT and analyzed Rpb1-CTD phosphorylation as reported in Fig. 1C  (upper panel) ; results showed no direct effect of 4-OHT in U2OS cells and confirmed that the hyper-phosphorylation of Rpb1-CTD in AsiSI cells is a consequence of sequence-specific DSBs. Moreover, we also assessed that 4-OHT administration to U2OS cells do not lead to ␥-H2AX foci formation (Fig. 1C, lower panel) .
The CTD domain of Rpb1 is a substrate of several kinases in vitro and in vivo. Notably, P-TEFb is the kinase responsible of Ser2 phosphorylation at the switch of transcription from initiation/pausing to processive elongation. We sought to determine whether P-TEFb might be the kinase responsible for the observed CTD hyperphosphorylation following AsiSI-dependent DNA cuts and to this end we treated cells with 4-OHT alone or in combination with flavopiridol (FP). FP is considered a potent inhibitor of CDKs with significant selectivity for CDK9 as its IC50 has been found to be about 7 times lower than that of the closest CDK IC50 reported to date [38] [39] [40] . As shown in Fig. 1 panel D , the ratio between II o and II a Rpb1 forms sharply decreases following co-treatments of cells with 4-OHT and FP. These results were confirmed by probing the extracts with anti-H5 antibody that recognizes the P-Ser2-CTD (Fig. 1E) . Albeit FP shows a high selectivity for CDK9, we cannot exclude that the observed effects could be also due to a concomitant FP inhibition of other cellular kinases. To further validate the role of CDK9 in the hyper-phosphorylation of Rpb1-CTD-(Ser2) following DSBs, we silenced CDK9 expression by using specific siRNAs. AsiSI were transfected with siRNAs targeting CDK9, as well as with scramble, non-targeting siRNAs for 48 h before treatment with 4-OHT. As shown in Fig. 1F , in cells silenced for CDK9 expression, 4-OHT-dependent CTD hyper-phosphorylation was impaired.
Collectively, these data showed that AsiSI-induced DSBs trigger hyper-phosphorylation of Rpb1-CTD at Ser2 and that P-TEFb is the kinase responsible for the most of the observed Rpb1-CTD-(Ser2) phosphorylation.
AsiSI-induced DSBs determine dissociation of the P-TEFb complex
It is known that initiation of transcriptional response following genotoxic stress induced by several DNA damaging agents causes a rapid release of P-TEFb from the inactive LC complex concurrent with Rpb1-CTD hyper-phosphorylation [17] [18] [19] [33] [34] [35] [36] .
To investigate if AsiSI-dependent DNA damage determines PTEFb dissociation, we analyzed the ratio between SC and LC forms of P-TEFb after treatment of cells with 4-OHT for different times by glycerol fractionation of cell lysates. Cellular lysates from AsiSI cells were ultracentrifuged on a glycerol gradient and the recovered fractions were analyzed by western blotting with anti-CDK9 and anti-HEXIM1 antibodies. As shown in Fig. 2A , treatment with 4-OHT shortly (1.5 h) determined dissociation of P-TEFb (compare NT and 4-OHT 1.5 h lanes 7-8, Fig. 2A ) that remained constant until 4 h of treatment (4-OHT 4 h lanes 7-8, Fig. 2A ). Since the dissociation is not complete, probably reflecting the slighter DNA damaging insult caused by AsiSI DSBs, we wished to further validate P-TEFb dissociation by co-immunoprecipitation analyses. Cyclin T1 associated proteins were immunoprecipitated in untreated, 4-OHT and control camptothecin (CPT) treated cells to investigate the presence of the CDK9 and Hexim1 proteins in the complex. As shown in Fig. 2B , dissociation of Hexim1 from the LC P-TEFb started at 2 h after treatment and increased at 4 h of 4-OHT treatment, to levels comparable to those obtained following CPT treatment. Collectively, these data demonstrated that sequence-specific DNA damage induced by AsiSI determines P-TEFb activation, which in turn is responsible for CTD-Ser2 hyperphosphorylation ( Figs. 1 and 2 ).
3.3. AsiSI-induced DSBs determine activation of the p53 transcriptional axis with a concomitant G2/M cell cycle arrest DNA damage alters the global pattern of gene expression that orchestrates a variety of cellular mechanisms including DNA repair, growth arrest and/or apoptosis. Following DNA damage, p53 is phosphorylated and thus activated by ATM and ATR kinases, as well as by their substrates Chk1 and Chk2 [1, 2] . The activated and stable p53 enhances the expression of several genes that cooperate to arrest cell cycle, as for example CDKN1A (p21) and GADD45a as well as to induce proapoptotic markers such as BBC3 (PUMA) and BAX.
Firstly, we determined whether AsiSI directed DNA breaks were sufficient to induce p53 and p21 gene expression. As shown in Fig. 3 (panel A), 4-OHT led to p53 accumulation, even though at lesser extent than drugs capable to induce genotoxicity and cellular stress (doxorubicin DXR, CPT, FP) or Nutlin-3, which disrupting p53-MDM2 interaction, releases the active form of p53 in the absence of DNA damage. According to these results, we also observed a concomitant increase of the p21 protein levels. Assuming by these findings the activation of the p53-dependent transcriptional pathway, we analyzed the expression levels of dedicated p53 gene targets as CDKN1A, BBC3, GADD45a and BAX by qRT-PCR. Our data show that site-specific DSBs induced by the AsiSI activity caused up-regulation of the p53-dependent analyzed genes (Fig. 3B) . Accordingly, CPT treatments also led to accumulation of CDKN1A and BAX, while BBC3 resulted unaffected and GADD45a downregulated. GADD45a down-regulation in presence of p53 over-expression is in agreement to published data [41] . Regarding BBC3, we speculate that the differences in BBC3 mRNA levels after treatments with CTP and 4-OHT are likely dependent on the specific cellular system used: it is reported that in the U2OS parental cell line, BBC3 overexpression following cisplatin administration is missing because of high presence of miR221-222 that directly targets BBC3 mRNA [42, 43] .
Since it is known that following UV-dependent DNA damage, Cyclin B1 and its kinase partner CDK1 are down-regulated due to reduction of GCN5 association to their respective promoter regions [44, 45] , we also looked at their expression. As shown in Fig. 3B , we observed reduction of Cyclin B1 and CDK1 expression following 4-OHT treatment.
We also analyzed p53-(Ser15) phosphorylation status and Cyclin B1 protein levels by comparing the effect of AsiSI-dependent DSBs to CPT treatment. As shown in Fig. 3C we observed increasing amount of phosphorylated p53 following 4-OHT treatment and CPT, and a relative small reduction of Cyclin B1 protein levels at 24 h after 4-OHT treatment.
To monitor cell cycle distribution upon induction of DSBs induced by AsiSI site-specific cuts, we performed monoparametric FACS analyses of propidium-stained cells upon drug administration and compared the results to those obtained by treatment with CPT. As shown in Fig. 4A , while cells treated with CPT arrested in G1, with cells in G1 phase increasing from 36% to 50% after drug administration, on sharp contrast, AsiSI-dependent DSBs determined G2/M arrest, with G2/M cells increasing from 16% to 46% following 4-OHT treatment. Our data are in agreement with previous report by the Legube group [46] ; besides, we show that cell cycle arrest at G2/M is already evident after 8 h of treatment with 4-OHT.
We also performed a bromodeoxyuridine/DNA (BrdU/DNA) biparametric flow cytometric analysis to obtain a distinct evaluation of cell cycle perturbations of cells that are in S phase (BrdU-positive cells) or in G1 or in G2/M (BrdU-negative cells) after AsiSI-induced DNA breaks [32] . (Fig. 4A and  B) .
Data presented here showed that DSBs induced by AsiSI activity determine down-regulation of Cyclin B1/CDK1 and the concomitant block of cell cycle in G2/M. The activated Cyclin B1/CDK1 complex exerts its role in promoting cells mitosis. In the presence of DSBs, it has been shown that p21 binds Cyclin B1/CDK1 to block its activity by nuclear retention [47, 48] . We speculate that the inhibition of Cyclin B1/CDK1 induced by AsiSI activity mimics the p21-mediated inhibition of the complex, thus halting cells in G2/M. However, further experiments could address this point.
Collectively, our results indicate that, in the inducible cellular system AsiSI the limited amount of breaks induced by the AsiSI enzyme is sufficient for the repartitioning of P-TEFb in the active SC; moreover, we suggest that the active CDK9 is responsible for induction of hyperphosphorylation of Rpb1-CTD in this system. We found that site-specific DSBs trigger the activation of genes that take part in TSR, namely p53, CDKN1A (p21), BBC3 (PUMA), GADD45a and BAX similarly to classical non site-specific inducers of DSBs. In contrast to the G1 arrest that follows CPT-mediated damage, in this cellular model we observed arrest in G2/M as consequence of AsiSIinduced DSBs.
Although we cannot exclude a variability of AsiSI enzyme efficiency among cells due to chromatin structure and accessibility, which could lead to a minor level of heterogeneity in the produced DNA cuts [28] , our data establish that the use of an inducible enzyme-based DNA damage cellular system may provide a useful experimental system not only for an in-depth understanding of chromatin dynamic involved in DSBs recognition, signaling and repair, but also in the genetic transcriptional reprogramming that follows DNA damage. 
